“Throughout my whole career I’m tested, I’ve never had any issues before. My team will find out why there’s been an adverse finding. The fight is still going ahead, I’m a clean athlete. We’ll get to the bottom of this. I’ll see you on Saturday.
“He [Eubank Jr] fully believes in me, it’s not who I am, it’s not what I’m about. He was understanding. We both want the fight to go ahead. As far as I’m concerned it is going ahead.”
A joint-statement from promoters Matchroom Boxing and Wasserman detailed a collective intent for the fight to take place on Saturday.
Sauerland also told Talksport: “It’s a non-performance enhancing drug, but it can raise testosterone.”
Despite the news, Eubank Jr “wishes to proceed” with Saturday’s catchweight main event at London’s O2 Arena.
Benn and Eubank Jr are set to face each other in a 157lbs catchweight contest, which will see the latter cut three pounds more than usual while Benn moves up two weight classes.
Wasserman’s Kalle Sauerland, who represents Eubank Jr, told Talksport on Wednesday: “The instant reaction is, ‘The fight is off…’ [but] the fight on Saturday is on.
“You have to look into what it is; a banned substance is a banned substance, end of. The scenario around it… how it could come to that, why are the other tests not positive? There’s been a big mistake here.
Recommended
“Has it been done as a PED [performance-enhancing drug]? No – that’s the medical opinions we have had.”
Benn and Eubank Jr’s fathers engaged in one of the most storied rivalries in British boxing history, with Chris Eubank stopping Benn in the ninth round of their first clash, in 1990, before they fought to a split draw in 1993 – almost 29 years to the day before this Saturday’s scheduled bout.
Register for free to continue reading
Registration is a free and easy way to support our truly independent journalism
By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists
{{#verifyErrors}} {{message}} {{/verifyErrors}} {{^verifyErrors}} {{message}} {{/verifyErrors}}
By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.
This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.
Already have an account? sign in
By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.
This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.
Register for free to continue reading
Registration is a free and easy way to support our truly independent journalism
By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists
{{#verifyErrors}} {{message}} {{/verifyErrors}} {{^verifyErrors}} {{message}} {{/verifyErrors}}
By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.
This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.
Already have an account? sign in
By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.
This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.
Source: Read Full Article
